Alaska Fund acquires a taste for big biotech startups

The $50 billion Alaska Permanent Fund, which handles the state's oil wealth, has invested $280 million in three biotechs: Juno ($JUNO), Denali and Codiak. And a story from Bloomberg's Doni Bloomfield notes that it works in the belief that patience is a competitive virtue when it comes to the life sciences. Interesting fact: All three startups it helped foster bear names linked to Alaska, which is far from the beaten track in biotech. Story

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.